Dae Won Kim, MD, discusses findings from the NAPOLI 3 trial that support the use of NALIRIFOX in patients with metastatic pancreatic cancer.
Dae Won Kim, MD
Advertisement
Articles by Dae Won Kim, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Full Approval to Pembrolizumab for Unresectable/Metastatic TMB-H Solid Tumors
2
HER2+ mCRC Treatment Sequencing Favors Tucatinib Plus Trastuzumab Before T-DXd
3
FDA Grants Orphan Drug Designation to Onvansertib for Chronic Myelomonocytic Leukemia
4
SBE303 Receives FDA Fast Track Designation in Pretreated Urothelial Cancer
5